Medicare Enrolled

Dr. Brian Huh, M.D.

Rheumatology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
520 S VIRGIL AVE STE 300, Los Angeles, CA 90020
2137360080
In practice since 2006 (19 years)
NPI: 1275614455 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Huh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Huh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Huh

Dr. Brian Huh is a rheumatology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Huh performed 7,955 Medicare services across 2,199 unique beneficiaries.

Between the years covered by Open Payments, Dr. Huh received a total of $122,567 from 41 pharmaceutical and/or device companies across 1077 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Huh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 24% volume in CA $122,567 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,955
Medicare services
Top 24% in CA for rheumatology
2,199
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~419 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 3,600 $18 $25
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,212 $69 $200
Hyaluronan injection (Euflexxa) for joint
An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space.
644 $98 $200
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
550 $64 $200
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
536 $10 $50
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
267 $50 $150
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
199 $45 $150
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
188 $80 $200
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
150 $78 $200
Methylprednisolone acetate injection, 20 mg
A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered.
121 $4 $30
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
109 $8 $20
Injection, methylprednisolone acetate, 40 mg 109 $5 $35
Tendon or ligament injection
A procedure involving the injection of medication into a tendon or ligament.
90 $49 $100
Methylprednisolone acetate injection, 80 mg
An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication.
83 $8 $40
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
47 $106 $200
Quadrivalent influenza vaccine, cell-culture derived
A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics.
25 $33 $50
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
25 $30 $30
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$122,567
Total received (2018-2024)
Avg $17,510/year across 7 years
Top 8% in CA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,077
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99,511 (81.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,387 (13.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,669 (5.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,207
2023
$1,930
2022
$6,423
2021
$16,998
2020
$10,935
2019
$49,682
2018
$34,392

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$591
ABBVIE INC.
$468
UCB, Inc.
$303
PFIZER INC.
$256
Janssen Biotech, Inc.
$144
AstraZeneca Pharmaceuticals LP
$118
Alexion Pharmaceuticals, Inc.
$109
GlaxoSmithKline, LLC.
$103
ANI Pharmaceuticals, Inc.
$81
Almatica Pharma LLC
$18
Novartis Pharmaceuticals Corporation
$16
Top 3 companies account for 61.7% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$63,652
GENZYME CORPORATION
$26,354
Regeneron Pharmaceuticals, Inc.
$6,669
Mallinckrodt LLC
$6,198
Regeneron Healthcare Solutions, Inc.
$4,421
PFIZER INC.
$2,116
ABBVIE INC.
$1,666
Janssen Biotech, Inc.
$1,335
UCB, Inc.
$1,252
AbbVie Inc.
$1,065
AbbVie, Inc.
$1,065
Lilly USA, LLC
$1,025
GlaxoSmithKline, LLC.
$902
Alexion Pharmaceuticals, Inc.
$844
Zimmer Biomet Holdings, Inc.
$633
Radius Health, Inc.
$554
AstraZeneca Pharmaceuticals LP
$323
Novartis Pharmaceuticals Corporation
$317
Ferring Pharmaceuticals Inc.
$310
Amarin Pharma Inc.
$265
Mallinckrodt Enterprises LLC
$205
Aurinia Pharma U.S., Inc.
$167
SANOFI-AVENTIS U.S. LLC
$157
Shire North American Group Inc
$145
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$131
Mallinckrodt Hospital Products Inc.
$121
Horizon Therapeutics plc
$115
ANI Pharmaceuticals, Inc.
$81
Genentech USA, Inc.
$78
Horizon Pharma plc
$75
SOBI, INC
$58
E.R. Squibb & Sons, L.L.C.
$50
Celltrion USA Inc.
$47
West-Ward Pharmaceuticals
$39
Celgene Corporation
$25
Flexion Therapeutics, Inc.
$23
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Sobi, Inc
$19
Almatica Pharma LLC
$18
DePuy Synthes Sales Inc.
$13
Osiris Therapeutics Inc.
$12
Top 3 companies account for 78.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · All T3 Implants · BENLYSTA · Bellatek · Bimzelx · COSENTYX · Cimzia · Diem2 · Doptelet · EUFLEXXA · EVENITY · EVUSHELD · Enbrel · FORTEO · GPS III PLATELET CONCENTRATION SYSTEM · GRAFIX/GRAFIXPL/STRAVIX · HUMIRA · Humira · KEVZARA · KEVZARA SARILUMAB INJECTION · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · NO PRODUCT DISCUSSED · OFEV · OLUMIANT · ORENCIA · ORTHOVISC · Otezla · PAXLOVID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · STRENSIQ · Sports Medicine Product Portfolio · Sports Medicine-None · Strensiq · TALTZ · TERIPARATIDE · TREMFYA · TRULANCE · Tymlos · UBRELVY · Vascepa · XELJANZ · XIFAXAN · XIIDRA · YUFLYMA · Zilretta · Zimmer Abutments
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for rheumatology in CA.

Looking for a rheumatology specialist in Los Angeles?
Compare rheumatologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
209
Per 100K population
2.1
County median income
$87,760
Nearest hospital
DOCS SURGICAL HOSPITAL
2.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Huh is a clinical cardiology specialist, with above-average Medicare volume (top 24% in CA), with speaking/promotional industry engagement in the top 8% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Huh experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Huh performed 3,600 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Huh receive payments from pharmaceutical companies?
Yes. Dr. Huh received a total of $122,567 from 41 companies across 1,077 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Huh's costs compare to other rheumatologists in Los Angeles?
Dr. Huh's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Huh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →